Aurealis Therapeutics
Multi-target cell and gene therapies for unmet medical needs.
17 employees · est. 2015 · Kuopio, Finland
Vyriad
Vyriad is a clinical-stage biotech company developing targeted genetic therapies that deliver genes directly to cells.
51 employees · est. 2015 · Rochester, United States
Vyriad is the larger of the two.
Side-by-Side Comparison
| Metric | Aurealis Therapeutics | Vyriad |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2015 |
| Headquarters | ||
| Headquarters | Kuopio, Finland | Rochester, United States |
| Employees | ||
| Employees | 17 | 51 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $10.00M | $88.38M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Development of Viral Platforms, Manufacturing of Genetic Therapies, Preclinical and Clinical Trial Management, Collaborative Research and Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Medical Institutions, Pharmaceutical Companies, Research Organizations, Healthcare Organizations |
| Taxonomy | ||
| Taxonomy | Cell And Gene Therapy, Recombinant Live Biotherapeutic, Chronic Wounds, Oncology, Advanced Therapy Medicinal Product, Inflammation, Oncolytic Bacteria | Biotech, Genetic Therapies, Oncolytic Virotherapy, Viral Vectors, Gene Editing, Cancer Treatment, Phase 1-2 Clinical Studies, Targeted Cell Therapy, Immuno-Oncology, Clinical Research Collaboration, Proprietary Oncolytic Virus, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Squamous Cell Carcinoma |
| Website | ||
| Website | aurealistherapeutics.com | vyriad.com |
About Aurealis Therapeutics
Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company that focuses on developing multi-target cell and gene therapies to address unmet medical needs in areas such as Chronic Wounds, deadly Cancers, and Inflammation. The company's platform is based on genetically modified saf...
About Vyriad
Vyriad, a United States-based clinical-stage biotech company, is making strides in the biotechnology sector by pioneering targeted genetic therapies. These therapies are designed to deliver genes directly to cells using engineered viruses, viral vectors, and envelope glycoproteins. The company's tec...
We will tell you when either one moves
BounceWatch watches Aurealis Therapeutics and Vyriad for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aurealis Therapeutics and Vyriad — by email.
Frequently Asked Questions
Compare Aurealis Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Aurealis Therapeutics on 12 Sep 2024, and Vyriad on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.